Adaptive Biotechnologies Corporation

Healthcare · Biotechnology · United States

Last price 26.64 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.25B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient’s body during and after treatment, known as Minima...